RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/26651826http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/26651826http://www.w3.org/2000/01/rdf-schema#comment"

Aim

Survivin expression was associated with unfavorable and erosive course of rheumatoid arthritis (RA). This is the first study investigating association between BIRC5 polymorphisms, survivin plasma levels and disease activity in RA.

Patients & methods

A testing group of 123 and validation group of 150 RA patients initially treated with methotrexate monotherapy were genotyped for three BIRC5 promoter polymorphisms. Survivin plasma levels were determined in testing group.

Results

BIRC5 c.-31G>C was marginally associated with treatment response after 6 months of methotrexate treatment (p = 0.046) and with DAS28 at the time of inclusion in testing (p = 0.052) and in validation group (p = 0.057). Survivin plasma levels were not associated with BIRC5 polymorphisms or DAS28.

Conclusion

BIRC5 -31C>G polymorphism could be useful pharmacogenetic marker for methotrexate treatment response in RA."xsd:string
http://purl.uniprot.org/citations/26651826http://purl.org/dc/terms/identifier"doi:10.2217/pgs.15.147"xsd:string
http://purl.uniprot.org/citations/26651826http://purl.uniprot.org/core/author"Dolzan V."xsd:string
http://purl.uniprot.org/citations/26651826http://purl.uniprot.org/core/author"Jenko B."xsd:string
http://purl.uniprot.org/citations/26651826http://purl.uniprot.org/core/author"Praprotnik S."xsd:string
http://purl.uniprot.org/citations/26651826http://purl.uniprot.org/core/author"Cucnik S."xsd:string
http://purl.uniprot.org/citations/26651826http://purl.uniprot.org/core/author"Tomsic M."xsd:string
http://purl.uniprot.org/citations/26651826http://purl.uniprot.org/core/author"Rotar Z."xsd:string
http://purl.uniprot.org/citations/26651826http://purl.uniprot.org/core/date"2016"xsd:gYear
http://purl.uniprot.org/citations/26651826http://purl.uniprot.org/core/name"Pharmacogenomics"xsd:string
http://purl.uniprot.org/citations/26651826http://purl.uniprot.org/core/pages"45-49"xsd:string
http://purl.uniprot.org/citations/26651826http://purl.uniprot.org/core/title"Survivin polymorphism is associated with disease activity in rheumatoid arthritis patients."xsd:string
http://purl.uniprot.org/citations/26651826http://purl.uniprot.org/core/volume"17"xsd:string
http://purl.uniprot.org/citations/26651826http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/26651826
http://purl.uniprot.org/citations/26651826http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/26651826
http://purl.uniprot.org/uniprot/#_A0A7L8XZM3-mappedCitation-26651826http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/26651826
http://purl.uniprot.org/uniprot/#_A0A0B4J1S3-mappedCitation-26651826http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/26651826
http://purl.uniprot.org/uniprot/#_A3E0Z5-mappedCitation-26651826http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/26651826
http://purl.uniprot.org/uniprot/#_A3E0Z6-mappedCitation-26651826http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/26651826
http://purl.uniprot.org/uniprot/#_A3E0Z7-mappedCitation-26651826http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/26651826
http://purl.uniprot.org/uniprot/#_A3E0Z8-mappedCitation-26651826http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/26651826
http://purl.uniprot.org/uniprot/#_B7Z7B9-mappedCitation-26651826http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/26651826
http://purl.uniprot.org/uniprot/#_A3E0Z4-mappedCitation-26651826http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/26651826
http://purl.uniprot.org/uniprot/#_E7CU85-mappedCitation-26651826http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/26651826